| 2025 | P/S | Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disor... | 
				    			
				    				
				    					|  | Invention | Compounds for treating tnbc. 
There is provided tinostamustine or a pharmaceutically acceptable s... | 
				    			
				    				
				    					|  | Invention | Tamper resistant dosage forms. The present invention relates to pharmaceutical dosage forms, for ... | 
				    			
				    				
				    					| 2024 | Invention | Tamper resistant dosage forms. 
The present invention relates to pharmaceutical dosage forms, for... | 
				    			
				    				
				    					|  | Invention | Sleep disorder treatment and prevention. 
The disclosure relates to methods for treating or preve... | 
				    			
				    				
				    					|  | Invention | Abuse deterrent morphine sulfate dosage forms. 
The present invention relates to a solid oral ext... | 
				    			
				    				
				    					|  | Invention | Sunobinop for use in method of treating alcohol use disorder. This disclosure relates to methods ... | 
				    			
				    				
				    					|  | Invention | Combination comprising a glucocorticoid and edo-s101. 
The present invention is directed to a com... | 
				    			
				    				
				    					|  | Invention | Pharmaceutical dosage forms. 
The invention relates to a solid dosage form comprising a core-shel... | 
				    			
				    				
				    					|  | Invention | Pharmaceutical combinations for treating cancer. The present invention is directed to a combinati... | 
				    			
				    				
				    					|  | Invention | Method of treatment and dosage forms thereof. 
The invention provides an oral dosage form compris... | 
				    			
				    				
				    					|  | Invention | Systems and methods for treating an opioid-induced adverse pharmacodynamic response. 
Disclosed i... | 
				    			
				    				
				    					|  | Invention | Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia. There is provided tin... | 
				    			
				    				
				    					|  | Invention | Combinations for treating cancer. 
The present invention relates to the use of tinostamustine or ... | 
				    			
				    				
				    					|  | Invention | Pharmaceutical dosage forms. 
The invention relates to a solid oral extended release pharmaceutic... | 
				    			
				    				
				    					|  | Invention | Encased tamper resistant controlled release dosage forms. 
In certain embodiments, the present in... | 
				    			
				    				
				    					|  | Invention | Tinostamustine for use in treating ovarian cancer. 
There is provided tinostamustine or a pharmac... | 
				    			
				    				
				    					| 2023 | Invention | Compositions and methods for opioid antagonist delivery. 
Disclosed in certain embodiments is a p... | 
				    			
				    				
				    					|  | Invention | Compounds for treating tnbc. There is provided tinostamustine or a pharmaceutically acceptable sa... | 
				    			
				    				
				    					|  | Invention | Treatment and prevention of sleep disorders. The disclosure relates to methods for treating or pr... | 
				    			
				    				
				    					|  | Invention | Methods of treating or preventing overactive bladder syndrome. The disclosure provides a method o... | 
				    			
				    				
				    					|  | Invention | Compositions and methods for opioid antagonist delivery. Disclosed in certain embodiments is a ph... | 
				    			
				    				
				    					|  | Invention | Tinostamustine for use in treating sarcoma. There is provided tinostamustine or a pharmaceuticall... | 
				    			
				    				
				    					|  | Invention | Encased tamper resistant controlled release dosage forms. In certain embodiments, the present inv... | 
				    			
				    				
				    					|  | Invention | Tamper resistant pharmaceutical formulations. 
Disclosed in certain embodiments is a solid oral d... | 
				    			
				    				
				    					|  | Invention | Sleep disorder treatment and prevention. The disclosure relates to methods for treating or preven... | 
				    			
				    				
				    					| 2022 | Invention | Morphinan derivatives and use thereof. 3, X, and n are defined as set forth in the specification.... | 
				    			
				    				
				    					|  | Invention | Combination comprising a glucocorticoid and edo-s101. The present invention is directed to a comb... | 
				    			
				    				
				    					|  | Invention | Compositions and methods for levodopa delivery. 
A pharmaceutical composition to treat Parkinson'... | 
				    			
				    				
				    					|  | Invention | Compositions and methods for levodopa delivery. A pharmaceutical composition to treat Parkinson's... | 
				    			
				    				
				    					|  | Invention | Methods and compositions particularly for treatment of attention deficit disorder. 
There is desc... | 
				    			
				    				
				    					|  | Invention | Compounds for treating brain cancer. There is provided a compound of formula I or a pharmacologic... | 
				    			
				    				
				    					|  | Invention | Methods of treating interstitial cystitis/bladder pain syndrome. 
The disclosure provides a metho... | 
				    			
				    				
				    					|  | Invention | Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia. T-PLL Therapy There i... | 
				    			
				    				
				    					|  | P/S | Pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdo... | 
				    			
				    				
				    					|  | P/S | Pharmaceutical preparations; pharmaceuticals. Pharmaceutical research and development. | 
				    			
				    				
				    					|  | Invention | Trace amine associated receptor 1 agonists and partial agonists for pain treatment. 
This applica... | 
				    			
				    				
				    					|  | Invention | Methods and compositions particularly for treatment of attention deficit disorder. There is descr... | 
				    			
				    				
				    					| 2021 | P/S | A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of cent... | 
				    			
				    				
				    					|  | Invention | Compositions and methods for levodopa delivery. 
Disclosed in certain embodiments is a method of ... | 
				    			
				    				
				    					|  | Invention | Compositions and methods for levodopa delivery. Disclosed in certain embodiments is a method of t... | 
				    			
				    				
				    					|  | Invention | Etoposide toniribate formulation. A liquid pharmaceutical formulation comprising etoposide toniri... | 
				    			
				    				
				    					|  | Invention | Compositions and methods for emergency rescue. 
Disclosed in certain embodiments is a parenteral ... | 
				    			
				    				
				    					|  | Invention | Compositions and methods for naloxone delivery. 
Disclosed in certain embodiments is a formulatio... | 
				    			
				    				
				    					| 2020 | Invention | Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound. Provided herein ... | 
				    			
				    				
				    					| 2019 | Invention | Compounds for treating lymphoma or a t-cell malignant disease. The invention relates to tinostamu... | 
				    			
				    				
				    					|  | Invention | Compounds for treating multiple myeloma. 
The invention relates to tinostamustine for use in the ... | 
				    			
				    				
				    					|  | P/S | Pharmaceutical preparations for the treatment of central nervous system disorders | 
				    			
				    				
				    					| 2018 | P/S | Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous sy... | 
				    			
				    				
				    					| 2014 | P/S | Analgesics | 
				    			
				    				
				    					| 2010 | P/S | Providing information regarding pharmaceutical products and healthcare in general via the Internet | 
				    			
				    				
				    					| 2003 | P/S | Informational services, namely providing information via a global computer network regarding phar... | 
				    			
				    				
				    					| 2000 | P/S | ANALGESIC PREPARATIONS | 
				    			
				    				
				    					|  | P/S | BROCHURES AND INFORMATION SHEETS IN THE MEDICAL AND HEALTHCARE FIELDS | 
				    			
				    				
				    					| 1996 | P/S | analgesic preparation | 
				    			
				    				
				    					| 1993 | P/S | educational material for the medical profession; namely, brochures in the field of pain management | 
				    			
				    				
				    					| 1992 | P/S | preparation for the relief of pain | 
				    			
				    				
				    					| 1983 | P/S | Analgesic Preparation | 
				    			
				    				
				    					| 1932 | P/S | MEDICAL COMPOUND FOR THE ALLEVIATION OF PAIN AND COUGH |